5 Value Stocks To Watch In The Healthcare Sector
5 Value Stocks To Watch In The Healthcare Sector
What Defines a Value Stock?
價值股票的定義是什麼？
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
傳統上，價值股是根據市場上投資者如何估值該公司的未來增長前景來定義的。低市盈率倍數是表明公司被低估的良好基礎指標，很可能被貼上價值股的標籤。
Below is a list of notable value stocks in the healthcare sector:
以下是醫療保健領域值得注意的價值股票清單：
- Kiora Pharmaceuticals (NASDAQ:KPRX) - P/E: 1.01
- Voyager Therapeutics (NASDAQ:VYGR) - P/E: 6.42
- Quoin Pharmaceuticals (NASDAQ:QNRX) - P/E: 2.39
- Procaps Gr (NASDAQ:PROC) - P/E: 7.27
- Solid Biosciences (NASDAQ:SLDB) - P/E: 0.1
- 基奧拉制藥（納斯達克股票代碼：KPRX）——市盈率：1.01
- Voyager Therapeutics（納斯達克股票代碼：VYGR）——市盈率：6.42
- Quoin Pharmicals（納斯達克股票代碼：QNRX）——市盈率：2.39
- Procaps Gr（納斯達克股票代碼：PROC）——市盈率：7.27
- Solid Biosciences（納斯達克股票代碼：SLDB）——市盈率：0.1
Kiora Pharmaceuticals's earnings per share for Q3 sits at $-0.89, whereas in Q2, they were at -0.79. Most recently, Voyager Therapeutics reported earnings per share at $-0.59, whereas in Q2 earnings per share sat at $-0.51. Quoin Pharmaceuticals has reported Q3 earnings per share at $-1.95, which has increased by 8.45% compared to Q2, which was -2.13. Most recently, Procaps Gr reported earnings per share at $0.08, whereas in Q2 earnings per share sat at $0.27. This quarter, Solid Biosciences experienced an increase in earnings per share, which was $-1.25 in Q2 and is now $-1.05.
Kiora Pharmicals第三季度的每股收益爲-0.89美元，而第二季度的每股收益爲-0.79美元。最近，Voyager Therapeutics公佈的每股收益爲-0.59美元，而第二季度的每股收益爲-0.51美元。Quoin Pharmicals公佈的第三季度每股收益爲-1.95美元，與第二季度的-2.13美元相比增長了8.45％。最近，Procaps Gr公佈的每股收益爲0.08美元，而第二季度的每股收益爲0.27美元。本季度，Solid Biosciences的每股收益有所增加，第二季度爲-1.25美元，目前爲-1.05美元。
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
意義：價值股可能需要一些時間才能從其被低估的位置中反彈。投資價值股的風險在於，這種出現可能永遠無法實現。
譯文內容由第三人軟體翻譯。